These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 4144533)
21. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
22. [Clinical aspects and therapy of ulcerative colitis]. Ziegler K Dtsch Z Verdau Stoffwechselkr; 1969; 29(4):319-29. PubMed ID: 4395145 [No Abstract] [Full Text] [Related]
23. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study. Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274 [TBL] [Abstract][Full Text] [Related]
24. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gorbach SL; Nahas L; Plaut AG; Weinstein L; Patterson JF; Levitan R Gastroenterology; 1968 Apr; 54(4):575-87. PubMed ID: 4385122 [No Abstract] [Full Text] [Related]
25. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. Frühmorgen P; Demling L Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627 [TBL] [Abstract][Full Text] [Related]
26. [Clinical observation on acupoint catgut embedding therapy for treatment of ulcerative colitis]. Li HJ; Li GP; Li HY Zhongguo Zhen Jiu; 2006 Apr; 26(4):261-3. PubMed ID: 16642612 [TBL] [Abstract][Full Text] [Related]
27. Proceedings: A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (salazopyrin). Dissanayake AS; Truelove SC Gut; 1973 Oct; 14(10):818. PubMed ID: 4148469 [No Abstract] [Full Text] [Related]
28. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease. Korelitz BI; Present DH; Rubin PH; Fochios SE J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary function in patients with inflammatory bowel disease. Eade OE; Smith CL; Alexander JR; Whorwell PJ Am J Gastroenterol; 1980 Feb; 73(2):154-6. PubMed ID: 6104919 [TBL] [Abstract][Full Text] [Related]
30. Loperamide: an open multicentre trial and double-blind cross-over comparison with placebo in patients with chronic diarrhoea. Demeulenaere L; Verbeke S; Muls M; Reyntjens A Curr Ther Res Clin Exp; 1974 Jan; 16(1):32-9. PubMed ID: 4203846 [No Abstract] [Full Text] [Related]
31. Ulcerative colitis in Thailand: a clinical study and long term follow-up. Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302 [TBL] [Abstract][Full Text] [Related]
32. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis. Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979 [TBL] [Abstract][Full Text] [Related]
34. [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis]. Rogozina VA; Rumiantsev VG Eksp Klin Gastroenterol; 2003; (1):58-9, 183. PubMed ID: 12664788 [TBL] [Abstract][Full Text] [Related]
35. Paradoxical response to heparin in 10 patients with ulcerative colitis. Gaffney PR; Doyle CT; Gaffney A; Hogan J; Hayes DP; Annis P Am J Gastroenterol; 1995 Feb; 90(2):220-3. PubMed ID: 7847289 [TBL] [Abstract][Full Text] [Related]
36. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Naganuma M; Iizuka B; Torii A; Ogihara T; Kawamura Y; Ichinose M; Kojima Y; Hibi T; Am J Gastroenterol; 2001 Apr; 96(4):1123-6. PubMed ID: 11316158 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up. Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349 [TBL] [Abstract][Full Text] [Related]
38. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis. Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868 [TBL] [Abstract][Full Text] [Related]
39. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study. Dickinson RJ; King A; Wight DG; Hunter JO; Neale G Dis Colon Rectum; 1985 Dec; 28(12):929-30. PubMed ID: 2866071 [TBL] [Abstract][Full Text] [Related]
40. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]